Literature DB >> 23370376

The human microbiome and autoimmunity.

Amy D Proal1, Paul J Albert, Trevor G Marshall.   

Abstract

PURPOSE OF REVIEW: To demonstrate how dysbiosis of the human microbiome can drive autoimmune disease. RECENT
FINDINGS: Humans are superorganisms. The human body harbors an extensive microbiome, which has been shown to differ in patients with autoimmune diagnoses. Intracellular microbes slow innate immune defenses by dysregulating the vitamin D nuclear receptor, allowing pathogens to accumulate in tissue and blood. Molecular mimicry between pathogen and host causes further dysfunction by interfering with human protein interactions. Autoantibodies may well be created in response to pathogens.
SUMMARY: The catastrophic failure of human metabolism observed in autoimmune disease results from a common underlying pathogenesis - the successive accumulation of pathogens into the microbiome over time, and the ability of such pathogens to dysregulate gene transcription, translation, and human metabolic processes. Autoimmune diseases are more likely passed in families because of the inheritance of a familial microbiome, rather than Mendelian inheritance of genetic abnormalities. We can stimulate innate immune defenses and allow patients to target pathogens, but cell death results in immunopathology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370376     DOI: 10.1097/BOR.0b013e32835cedbf

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  36 in total

Review 1.  Rethinking mechanisms of autoimmune pathogenesis.

Authors:  Shiv Pillai
Journal:  J Autoimmun       Date:  2013-06-25       Impact factor: 7.094

2.  How Should Biobanks Prioritize and Diversify Biosample Collections? A 40-Year Scientific Publication Trend Analysis by the Type of Biosample.

Authors:  Jae-Eun Lee; Young-Youl Kim
Journal:  OMICS       Date:  2018-03-27

3.  The lung may play a role in the pathogenesis of rheumatoid arthritis.

Authors:  M Kristen Demoruelle; Joshua J Solomon; Aryeh Fischer; Kevin D Deane
Journal:  Int J Clin Rheumtol       Date:  2014

4.  Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis.

Authors:  Jennifer S Graves; Tanuja Chitnis; Bianca Weinstock-Guttman; Jennifer Rubin; Aaron S Zelikovitch; Bardia Nourbakhsh; Timothy Simmons; Michael Waltz; T Charles Casper; Emmanuelle Waubant
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

Review 5.  Ameliorating Role Exerted by Al-Hijamah in Autoimmune Diseases: Effect on Serum Autoantibodies and Inflammatory Mediators.

Authors:  Hussam Baghdadi; Nada Abdel-Aziz; Nagwa Sayed Ahmed; Hany Salah Mahmoud; Ayman Barghash; Abdullah Nasrat; Manal Mohamed Helmy Nabo; Salah Mohamed El Sayed
Journal:  Int J Health Sci (Qassim)       Date:  2015-04

Review 6.  Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies.

Authors:  Eric Meffre; Kevin C O'Connor
Journal:  Immunol Rev       Date:  2019-11-12       Impact factor: 10.983

Review 7.  Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective.

Authors:  Molly Fox; Delaney A Knorr; Kacey M Haptonstall
Journal:  Ann N Y Acad Sci       Date:  2019-06-10       Impact factor: 6.499

Review 8.  Prospects for therapeutic tolerance in humans.

Authors:  Kenneth F Baker; John D Isaacs
Journal:  Curr Opin Rheumatol       Date:  2014-03       Impact factor: 5.006

9.  Intestinal microbiota and active systemic lupus erythematosus: a systematic review.

Authors:  Juliana Rosa Pires Vieira; Andréa Toledo de Oliveira Rezende; Marcos Rassi Fernandes; Nilzio Antonio da Silva
Journal:  Adv Rheumatol       Date:  2021-07-02

10.  The vitamin d receptor and T cell function.

Authors:  Martin Kongsbak; Trine B Levring; Carsten Geisler; Marina Rode von Essen
Journal:  Front Immunol       Date:  2013-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.